Off-label Use Analysis of Tacrolimus Combined with Wuzhi Capsules in One Membranous Nephropathy Patient / 中国药师
China Pharmacist
;
(12): 1908-1910, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-503268
ABSTRACT
Objective:
To investigate the rationality of off-label use of tacrolimus combined with Wuzhi capsules in a membranous nephropathy patient.Methods:
Based on the related literatures, the application rationality of tacrolimus combined with Wuzhi capsules in a membranous nephropathy patient was analyzed.Results:
The combination of tacrolimus and Wuzhi capsules against membranous nephropathy was an off -label drug use, however, it showed certain clinical rationality and economic efficiency.Conclusion:
Off-label drug use commonly exists in clinics. Clinical pharmacists should provide evidence support for off-label drug use through searching and analyzing clinical evidences and closely monitoring therapeutic outcome.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacist
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS